Evidence map›Paper›PMID 28487220›Full record

ArticleBehavioural brain research2017

Variant in a common odorant-binding protein gene is associated with bitter sensitivity in people.

Iole Tomassini Barbarossa, M Hakan Ozdener, Melania, Latisha Love-Gregory, Makedonka Mitreva, Nada A Abumrad, M Yanina Pepino

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Effect of theFoods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Obesity and COVID-19: Oro-Naso-Sensory Perception.Journal of clinical medicine · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Iole Tomassini BarbarossaUniversity of Cagliari, Monserrato, CA, I 09042, Italy.
M Hakan OzdenerMonell Center, Philadelphia, PA, 19130, USA.
MelaniaUniversity of Cagliari, Monserrato, CA, I 09042, Italy.
Latisha Love-GregoryWashington University School of Medicine, St. Louis, MO, 63110, USA.
Makedonka MitrevaWashington University School of Medicine, St. Louis, MO, 63110, USA.
Nada A AbumradWashington University School of Medicine, St. Louis, MO, 63110, USA.
M Yanina PepinoUniversity of Illinois at Urbana Champaign, Urbana, IL, 61801, USA. Electronic address: ypepino@illinois.edu.
Washington University in St. Louis · USUniversity of Cagliari · ITMonell Chemical Senses Center · USUniversity of Illinois Urbana-Champaign · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
CD36 AND INTESTINAL FAT ABSORPTIONR01DK060022 · NIDDK · WASHINGTON UNIVERSITY · PI ABUMRAD, NADA A. · 2001 to 2021
$7.7M
FATTY ACID TRANSPORTER: REGULATION, IDENTIFICATIONR01DK033301 · NIDDK · WASHINGTON UNIVERSITY · PI ABUMRAD, NADA A. · 1986 to 2017
$5.2M
Molecular BiologyP30DC011735 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI MOSINGER, BEDRICH · 2011 to 2015
$2.5M
NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NIDCD NIH HHS P30 DC011735NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK033301NIDDK NIH HHS R01 DK060022
6 · The paper itself

Abstract

Deeper understanding of signaling mechanisms underlying bitterness perception in people is essential for designing novel and effective bitter blockers, which could enhance nutrition and compliance with orally administered bitter-tasting drugs. Here we show that variability in a human odorant-binding protein gene, OBPIIa, associates with individual differences in bitterness perception of fat (oleic acid) and of a prototypical bitter stimulus, 6-n-propylthiouracil (PROP), suggesting a novel olfactory role in the modulation of bitterness sensitivity.

Indexed as

AdultCalciumEpithelial CellsFemaleFood PreferencesGenotypeHumansLipocalinsMaleOdorantsOleic AcidOlfactory MucosaPsychophysicsTasteTaste PerceptionUracil6-n-propyluracilCalciumLipocalinsOBP2A protein, humanOleic AcidUracilBitter tasteIndividual differencesOlfactionOlfactory binding proteinPROPSmell

Identifiers

PMID28487220
PMCPMC5534261
OpenAlexW2611195366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.